The adenylate cyclase toxins of bacillus anthracis and bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling

PLoS Pathogens

Volumn 5, Issue 3, 2009, Pages

  Paccani, Silvia Rossi ^a   Benagiano, Marisa ^b   Capitani, Nagaja ^a   Zornetta, Irene ^c   Ladant, Daniel ^d   Montecucco, Cesare ^c   D'Elios, Mario M ^b   Baldari, Cosima T ^a,e  

^a UNIVERSITY OF SIENA   (Italy)

^b Department of Internal Medicine and Immunoallergology ^*  (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; AKT1 ENZYME; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN KINASE ZAP 70; PROTEIN VAV1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GATA3 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; MAF PROTEIN, HUMAN;

ARTICLE; BACILLUS ANTHRACIS; BORDETELLA PERTUSSIS; CATALYSIS; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; CELL DIFFERENTIATION; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

ADENYLATE CYCLASE TOXIN; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BORDETELLA PERTUSSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MAF; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 63449132380     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000325     Document Type: Article

References (60)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793.
2. Glimcher LH, Murphy KM (2000) Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 14: 1693-1711.
3. Norgauer J, Ibig Y, Gmeiner D, Herouy Y, Fiebich BL (2003) Prostaglandin E2 synthesis in human monocyte-derived dendritic cells. Int J Mol Med 12: 83-86.
4. Siegel MD, Zhang DH, Ray P, Ray A (1995) Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J Biol Chem 270: 24548-24555.
5. Lacour M, Arrighi JF, Muller KM, Carlberg C, Saurat JH, et al. (1994) cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 6: 1333-1343.
6. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, WijdenesJ, Aarden LA (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775-779.
7. Klein-Hessling S, Jha MK, Santner-Nanan B, Berberich-Siebelt F, Baumruker T, et al. (2003) Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells. J Immunol 170: 2956-2961.
8. Tokoyoda K, Tsujikawa K, Matsushita H, Ono Y, Hayashi T, et al. (2004) Up- regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells. Int Immunol 16: 643-653.
9. Nirula A, Ho M, Phee H, Roose J, Weiss A (2006) Phosphoinositide- dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4. J Exp Med 203: 1733-1744.
10. Freytag LC, Clements JD (1999) Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 236: 215-236.
11. Young JA, Collier RJ (2007) Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 76: 243-265.
12. VojtovaJ, KamanovaJ, Sebo P (2006) Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr Opin Microbiol 9: 69-75.
13. Ross PJ, Lavelle EC, Mills KH, Boyd AP (2004) Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 72: 1568-1579.
14. Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, et al. (2006) Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Infect Immun 74:6797-6805.
15. Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, et al. (2005) Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol 175: 730-738.
16. Duverger A, Jackson RJ, van Ginkel FW, Fischer R, Tafaro A, et al. (2006) Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol 176: 1776-1783.
17. Quesnel-Hellmann A, Cleret A, Vidal DR, Tournier JN (2006) Evidence for adjuvanticity of anthrax edema toxin. Vaccine 24: 699-702.
18. Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, et al. (2006) Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun 74: 2831-2838.
19. Hickey FB, Brereton CF, Mills KH (2008) Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol 84: 234-243.
20. Kubo S, Takahashi HK, Takei M, Iwagaki H, Yoshino T, et al. (2004) E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte- derived dendritic cells and induction of helper T2 polarization. J Pharmacol Exp Ther 309: 1213-1220.
21. Bagley KC, Abdelwahab SF, Tuskan RG, Lewis GK (2006) Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide. Clin Vaccine Immunol 13: 106-115.
22. Paccani SR, Tonello F, Ghittoni R, Natale M, Muraro L, et al. (2005) Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med 201: 325-331.
23. Comer JE, Chopra AK, Peterson JW, Konig R (2005) Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun 73: 8275-8281.
24. Paccani SR, Dal Molin F, Benagiano M, Ladant D, D'Elios MM, et al. (2008) Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. Infect Immun 76: 2822-2832.
25. Shen Y, Zhukovskaya NL, Guo Q, Florian J, Tang WJ (2005) Calcium- independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor. Embo J 24: 929-941.
26. Ladant D, Glaser P, Ullmann A (1992) Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J Biol Chem 267: 2244-2250.
27. Tasken K, Stokka AJ (2006) The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem Soc Trans 34: 476-479.
28. Tanaka Y, So T, Lebedeva S, Croft M, Altman A (2005) Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood 106: 1286-1295.
29. Dodeller F, Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H (2005) The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur J Immunol 35: 3631-3642.
30. Schafer PH, Wadsworth SA, Wang L, Siekierka JJ (1999) p38α mitogen- activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells. J Immunol 162: 7110-7119.
31. Chen CH, Zhang DH, LaPorte JM, Ray A (2000) Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol 165: 5597-5605.
32. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, et al. (2007) Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 178: 2491-2498.
33. Yu CT, Shih HM, Lai MZ (2001) Multiple signals required for cyclic AMP- responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation. J Immunol 166: 284-292.
34. Hewlett EL, Donato GM, Gray MC (2006) Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol 59: 447-459.
35. Scobie HM, Wigelsworth DJ, Marlett JM, Thomas D, Rainey GJ, et al. (2006) Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. PLoS Pathog 2: e111. doi:10.1371/journal.ppat.0020111.
36. Knapp O, Maier E, Masin J, Sebo P, Benz R (2008) Pore formation by the Bordetella adenylate cyclase toxin in lipid bilayer membranes: role of voltage and pH. Biochim Biophys Acta 1778: 260-269.
37. Abrahamsen H, Baillie G, Ngai J, Vang T, Nika K, et al. (2004) TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling. J Immunol 173: 4847-4858.
38. Wang L, Liu F, Adamo ML (2001) Cyclic AMP inhibits extracellular signal- regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem 276: 37242-37249.
39. Lou L, Urbani J, Ribeiro-Neto F, Altschuler DL (2002) cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b. J Biol Chem 277:32799-32806.
40. Gulbranson-Judge A, Tybulewicz VL, Walters AE, Toellner KM, MacLennan IC, et al. (1999) Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur J Immunol 29: 477-487.
41. Paccani SR, Patrussi L, Ulivieri C, Masferrer JL, D'Elios MM, et al. (2005) Nonsteroidal anti-inflammatory drugs inhibit a Fyn-dependent pathway coupled to Rac and stress kinase activation in TCR signaling. Blood 105: 2042-2048.
42. Davidson D, Shi X, Zhang S, Wang H, Nemer M, et al. (2004) Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase Fyn T in T(H)2 cytokine regulation. Immunity 21: 707-717.
43. Cannons JL, Yu LJ, Hill B, Mijares LA, Dombroski D, et al. (2004) SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 21: 693-706.
44. 2 integrin (CD11b/CD18). J Exp Med 193: 1035-1044.
45. Dal Molin F, Tonello F, Ladant D, Zornetta I, Zamparo I, et al. (2006) Cell entry and cAMP imaging of anthrax edema toxin. EMBO J25: 5405-5413.
46. Dal Molin F, Zornetta I, Puhar A, Tonello F, Zaccolo M, et al. (2008) cAMP imaging of cells treated with pertussis toxin, cholera toxin, and anthrax edema toxin. Biochem Biophys Res Commun 376: 429-433.
47. Puhar A, Dal Molin F, Horvath S, Ladants D, Montecucco C (2008) Anthrax edema toxin modulates PKA- and CREB-dependent signaling in two phases. PLoS ONE 3: e3564. doi:10.1371/journal.pone.0003564.
48. McConnachie G, Langeberg LK, Scott JD (2006) AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med 12: 317-323.
49. Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, et al. (2005) Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174: 4934-4941.
50. Quinn CP, Dull PM, Semenova V, Li H, Crotty S, et al. (2004) Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism- related cutaneous or inhalation anthrax. J Infect Dis 190: 1228-1236.
51. Harrison LH, Ezzell JW, Abshire TG, Kidd S, Kaufmann AF (1989) Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis 160: 706-710.
52. Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, et al. (2004) Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Vaccine 22: 4270-4281.
53. Hormozi K, Parton R, Coote J (1999) Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. FEMS Immunol Med Microbiol 23: 273-282.
54. Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, et al. (2003) Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101: 611-620.
55. Behrens EM, Sriram U, Shivers DK, Gallucci M, Ma Z, et al. (2007) Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J Immunol 178: 6268-6279.
56. Preville X, Ladant D, Timmerman B, Leclerc C (2005) Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res 65:641-649.
57. Tonello F, Naletto L, Romanello V, Dal Molin F, Montecucco C (2004) Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis. Biochem Biophys Res Commun 313: 496-502.
58. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, et al. (2003) The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. JExp Med 198: 1887-1897.
59. Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, et al. (2006) The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116: 1092-1101.
60. -ΔΔCT Method. Methods 25: 402-408.